Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells (Q38338004)

2 September 2017

title

Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells (English)

1 reference

2 September 2017

0 references

1 reference

Chen YQ

1 reference

2 September 2017

Su M

1 reference

2 September 2017

Walia RR

1 reference

2 September 2017

Hao Q

1 reference

2 September 2017

Covington JW

1 reference

2 September 2017

Vaughan DE

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

inferred from page(s)

published in

1 reference

2 September 2017

volume

273

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

8225-8231

1 reference

Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Role of oxidative stress in development of complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Sp1 mediates glucose activation of the acetyl-CoA carboxylase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Multiple enhancer elements mediate induction of c-fos in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

A common response element mediates differential effects of phorbol esters and forskolin on type-1 plasminogen activator inhibitor gene expression in human breast carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Metabolic regulation of gene transcription in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

The insulin gene contains multiple transcriptional elements that respond to glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Glucose-induced transcription of the insulin gene is mediated by factors required for beta-cell-type-specific expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Proteinases and extracellular matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.14.8225

21 January 2018

Identifiers

DOI

10.1074/JBC.273.14.8225

1 reference

2 September 2017

1 reference